About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Clinical Trials in Arizona | 16,611 Studies Near You

Clinical TrialsArizona

Clinical Trials in Arizona

Discover 16,611 clinical trials near Arizona. Find research studies in your area.

Browse by condition:

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma Pancreatic Cancer

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 3441-3460 of 16,611 trials

CompletedCMA-676 in Treating Patients With Acute Myeloid Leukemia in First RelapseRATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die.NCT00003131·Tucson, Arizona and 12 others CompletedA Post-Market Study Evaluating the Safety of Infinity DBS System With MR Conditional LabelingThe Infinity MRI PMCF was conducted as an international, multicenter, observational, prospective, single-arm, post-market clinical follow-up (PMCF) study.NCT03884231·Tucson, Arizona and 15 others

Find Trials by Condition in Arizona

Breast Cancerin Arizona Lung Cancerin Arizona Prostate Cancerin Arizona Colorectal Cancerin Arizona Melanomain Arizona Leukemiain Arizona Lymphomain Arizona Pancreatic Cancerin Arizona Ovarian Cancerin Arizona Brain Cancerin Arizona Diabetes

Data from ClinicalTrials.govTerms

No longer availableExpanded Access Program to Provide Treatment With Pitolisant to Adult Patients in the U.S. With Excessive Daytime Sleepiness Associated With Narcolepsy With or Without CataplexyThis EAP will be open to provide access to treatment with pitolisant while a U.S. New Drug Application (NDA) is being prepared and submitted for review for marketing approval.NCT03433131·Birmingham, Alabama and 70 others

CompletedLong-Term Outcomes of Ataluren in Duchenne Muscular DystrophyThis study is a long-term study of ataluren in participants with nonsense mutation Duchenne muscular dystrophy.NCT03179631·Phoenix, Arizona and 63 others

CompletedAn Open-Label Study of JZP-458 (RC-P) in Patients With Acute Lymphoblastic Leukemia (ALL)/Lymphoblastic Lymphoma (LBL)This is an open-label, multicenter, dose confirmation, and PK study of JZP-458 in patients (of any age) with ALL/LBL who are hypersensitive to E. coli-derived asparaginases…NCT04145531·Birmingham, Alabama and 73 others

CompletedNINDS CRC Chronic Migraine Treatment TrialThe purpose of this study is to compare the reduction in the number of severe headache days at six months in people with chronic migraine treated with topiramate and propranolol…NCT00772031·Phoenix, Arizona and 38 others

UnknownPDGeneration: Mapping the Future of Parkinson's DiseaseTo assess the feasibility, impact, and participant satisfaction of offering Clinical Laboratory Improvement Amendments (CLIA) certified genetic testing as part of clinical care…NCT04057794·Phoenix, Arizona and 12 others

Active not recruitingStudying the Effect of Levocarnitine in Protecting the Liver From Chemotherapy for Leukemia or LymphomaThis phase III trial compares the effect of adding levocarnitine to standard chemotherapy versus (vs.) standard chemotherapy alone in protecting the liver in patients with…NCT05602194·Birmingham, Alabama and 227 others

CompletedPlacebo Controlled, Randomized Safety and Efficacy Study of RC-1291 in Cancer Anorexia/CachexiaActivation of Ghrelin receptors have been demonstrated to stimulate appetite.NCT00378131·Glendale, Arizona and 16 others

CompletedClinical Study to Evaluate Mavacamten (MYK-461) in Adults With Symptomatic Obstructive Hypertrophic CardiomyopathyThis is a multicenter, international, double-blind study of the administration of mavacamten in participants with symptomatic obstructive HCM (oHCM).NCT03470545·Scottsdale, Arizona and 70 others

CompletedSafety and Treatment Satisfaction in Adults With Chronic ITP After Switching to Avatrombopag From Eltrombopag or RomiplostimEvaluate the safety and tolerability of avatrombopag given for 90 days after stopping treatment with eltrombopag or romiplostim.NCT04638829·Tucson, Arizona and 19 others

CompletedMuscle Growth Following a Resistance Training Program in Men and Women Consuming Protein SupplementsSoy and whey protein have different concentrations of leucine, an amino acid known to be a particularly potent simulator of muscle protein synthesis.NCT03868631·Phoenix, Arizona

UnknownEfficacy and Safety of 2 Doses of AQX-1125 in Subjects With Interstitial Cystitis / Bladder Pain SyndromeThis study evaluates the effects of two doses of oral AQX-1125 on bladder pain and other urinary symptoms in subjects with interstitial cystitis/bladder pain syndrome.NCT02858453·Homewood, Alabama and 119 others

CompletedTrial to Evaluate Efficacy and Safety of Lenabasum in Cystic FibrosisThis is a Phase 2 multicenter, double-blind, randomized, placebo-controlled study assessing the efficacy and safety of lenabasum for the treatment of cystic fibrosis in patients…NCT03451045·Phoenix, Arizona and 104 others

CompletedComparing the Efficacy of Tiotropium + Olodaterol (5/5 µg) Fixed Dose Combination (FDC) Over Tiotropium 5µg in Reducing Moderate to Severe Exacerbations in Patients With Severe to Very Severe Chronic Obstructive Pulmonary Disease.The overall objective is to assess the effect of once daily tiotropium + olodaterol fixed dose combination compared to 5 µg tiotropium (both delivered with the Respimat® inhaler)…NCT02296138·Andalusia, Alabama and 817 others

CompletedRetreatment of Recurrent Dupuytren's ContracturesThe objectives of this study are to assess the safety and efficacy of AA4500 in the retreatment of recurrent contractures in joints that were effectively treated with AA4500 in a…NCT01498640·Phoenix, Arizona and 12 others

CompletedEfficacy and Safety of Oral Ibrexafungerp (SCY-078) vs. Placebo in Subjects With Acute Vulvovaginal Candidiasis (VANISH 303)This is a Phase 3, randomized, multicenter, double-blind, placebo-controlled study to evaluate the efficacy and safety of oral Ibrexafungerp (SCY-078) compared to placebo in…NCT03734991·Birmingham, Alabama and 24 others

WithdrawnAn Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal MenThis is an open-study with a 26 week open label treatment period followed by an optional 26 week open label extension. The total treatment period will be 52 weeks.NCT02082197·Birmingham, Alabama and 41 others

TerminatedFeasibility of Using a Mobile Device Controlled Micro-pressure Pulse Insufflator for Acute Migraine ReliefEvaluate the feasibility of using a mobile interface to control the insufflator device administering treatment for aborting (stopping) an acute episode of migraine.NCT03263897·Prescott, Arizona and 1 other

CompletedIntegrated Second Language Learning for Chronic CareLanguage barriers continue to impede access to quality care for limited English proficient populations.NCT02864160·Tucson, Arizona and 1 other

PreviousPage 173 of 831Next

in Arizona

Heart Diseasein Arizona